News - Halo Pharmaceuticals - Page 2

Capabilities

Explore our technical areas of focus

Development

Analytical

Clinical

Commercial

Quality
Dosage Forms

From liquids to injectables – see the formats we deliver

Solids

Semi-Solids

Oral Liquids

Sterile
(Operational in 2026)
Facilities

Take a look inside our world-class operations

Whippany, NJ

Provides non-GMP and cGMP formulation development to commercial manufacturing services.

learn more

Mirabel, Quebec, Canada

Capable of non-gmp/cGMP pharmaceutical development and commercial manufacturing.

learn more

Take a look inside our world-class operations

Whippany, NJ

Mirabel, Quebec, Canada
Who We Help
Who We Are

History, Expertise and News – all in one place

History

Leadership

Applied Expertise

News and Events

Connect with us on LinkedIn

Linkedin

Latest News

Halo Pharma Set to Launch New Sterile Injectable Manufacturing Capabilities at Whippany Facility

August 21, 2026
Read More »

Inside Halo’s New Fill-Finish Platform

August 13, 2026
Read More »

Upcoming Events
Open Invitation

Let’s connect, collaborate and build something lasting together

Let's Collaborate

Careers

Let's Connect
Contact Us

Linkedin

Connect with us on LinkedIn

Job Offer Scam Warning

Learn More

The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing

WILMINGTON, Del. and WHIPPANY, New High-Speed Filling Line to Support Growing Demand for Sterile Injectables and Strengthen Domestic Supply Chain Learn More About Halo Pharma’s